Hartline Investment Corp Bristol Myers Squibb CO Transaction History

Hartline Investment Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $728,384 - $825,846	15,181 Added 387.47%	19,099 $1.04 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $20,387 - $22,636	-320 Reduced 7.55%	3,918 $250,000
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $290,218 - $343,659	4,238 New	4,238 $304,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $977,247 - $1.08 Million	13,457 Added 102.21%	26,623 $2.05 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $216,286 - $259,346	3,518 Added 36.46%	13,166 $961,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $174,565 - $203,502	-3,255 Reduced 25.23%	9,648 $602,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $15,561 - $18,228	-263 Reduced 2.0%	12,903 $763,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $134,158 - $146,099	-2,167 Reduced 14.13%	13,166 $880,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $669,948 - $753,494	-11,290 Reduced 42.41%	15,333 $968,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $451,353 - $511,466	-7,817 Reduced 22.7%	26,623 $1.65 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $1.89 Million - $2.1 Million	-32,937 Reduced 48.88%	34,440 $2.08 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $509,771 - $595,972	-9,299 Reduced 12.13%	67,377 $3.96 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $72,616 - $105,527	-1,565 Reduced 2.0%	76,676 $4.27 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $3.85 Million - $5.02 Million	78,241 New	78,241 $5.02 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Hartline Investment Corp with notifications on news.